XML 35 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets and Goodwill (Tables)
6 Months Ended
Jun. 30, 2012
Intangible Assets and Goodwill  
Schedule of intangible assets by category

 

 

 

 

Gross

 

 

 

Intangible

 

Weighted

 

 

 

Carrying

 

Accumulated

 

Assets,

 

Average

 

June 30, 2012

 

Value

 

Amortization

 

Net

 

Life (Years)

 

 

 

 

 

 

 

 

 

 

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

Acquired developed product rights

 

 $

2,186,000

 

 $

(732,803)

 

 $

1,453,197

 

11.9

 

Technology

 

333,333

 

(16,069)

 

317,264

 

7.0

 

Licenses

 

64,250

 

(8,026)

 

56,224

 

16.8

 

Other

 

41,376

 

(12,359)

 

29,017

 

8.8

 

 

 

2,624,959

 

(769,257)

 

1,855,702

 

11.3

 

 

 

 

 

 

 

 

 

 

 

Non-amortized intangible assets:

 

 

 

 

 

 

 

 

 

Acquired IPR&D product rights

 

1,410,248

 

-  

 

1,410,248

 

 

 

 

 

 

 

 

 

 

 

 

 

Total intangible assets

 

 $

4,035,207

 

 $

(769,257)

 

 $

3,265,950

 

 

 

 

 

 

Gross

 

 

 

Intangible

 

Weighted

 

 

 

Carrying

 

Accumulated

 

Assets,

 

Average

 

December 31, 2011

 

Value

 

Amortization

 

Net

 

Life (Years)

 

 

 

 

 

 

 

 

 

 

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

Acquired developed product rights

 

 $

2,186,000

 

 $

(666,142)

 

 $

1,519,858

 

11.9

 

Technology

 

2,534

 

(190)

 

2,344

 

10.0

 

Licenses

 

64,250

 

(6,108)

 

58,142

 

16.8

 

Other

 

40,600

 

(10,246)

 

30,354

 

8.8

 

 

 

2,293,384

 

(682,686)

 

1,610,698

 

11.9

 

 

 

 

 

 

 

 

 

 

 

Non-amortized intangible assets:

 

 

 

 

 

 

 

 

 

Acquired IPR&D product rights

 

1,234,000

 

-  

 

1,234,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Total intangible assets

 

 $

3,527,384

 

 $

(682,686)

 

 $

2,844,698

Schedule of changes in carrying value of goodwill

 

 

Balance at December 31, 2011

 

$

1,887,220

 

Acquisition of Avila (see Note 3)

 

153,989

 

Tax benefit on the exercise of Pharmion converted stock options

 

(429)

 

Balance at June 30, 2012

 

$

2,040,780